{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:13:54Z","timestamp":1792782834680,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T00:00:00Z","timestamp":1641600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T00:00:00Z","timestamp":1641600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Youth Fund Project of Natural Science Foundation of China","award":["81900664"],"award-info":[{"award-number":["81900664"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s10157-021-02173-x","type":"journal-article","created":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T01:02:49Z","timestamp":1641603769000},"page":"385-397","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["KCNQ1OT1 inhibition alleviates high glucose-induced podocyte injury by adsorbing miR-23b-3p and regulating Sema3A"],"prefix":"10.1007","volume":"26","author":[{"given":"Bingru","family":"Fei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengjiao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,8]]},"reference":[{"issue":"Pt 5","key":"2173_CR1","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1042\/BST0360941","volume":"36","author":"M Murphy","year":"2008","unstructured":"Murphy M, Crean J, Brazil DP, Sadlier D, Martin F, Godson C. Regulation and consequences of differential gene expression in diabetic kidney disease. Biochem Soc Trans. 2008;36(Pt 5):941\u20135.","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"2173_CR2","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.dsx.2018.11.054","volume":"13","author":"VRA\/LB Vasanth Rao","year":"2019","unstructured":"Vasanth Rao VRA\/LB, Tan SH, Candasamy M, Bhattamisra SK. Diabetic nephropathy: an update on pathogenesis and drug development. Diabetes Metab Syndr. 2019;13(1):754\u201362.","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"2173_CR3","doi-asserted-by":"publisher","first-page":"8888","DOI":"10.1038\/s41598-019-45303-y","volume":"9","author":"A Schwarz","year":"2019","unstructured":"Schwarz A, M\u00f6ller-Hackbarth K, Ebarasi L, Unnersj\u00f6 Jess D, Zambrano S, Blom H, Wernerson A, Lal M, Patrakka J. Coro2b, a podocyte protein downregulated in human diabetic nephropathy, is involved in the development of protamine sulphate-induced foot process effacement. Sci Rep. 2019;9(1):8888.","journal-title":"Sci Rep"},{"issue":"6","key":"2173_CR4","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.2337\/diabetes.54.6.1626","volume":"54","author":"G Wolf","year":"2005","unstructured":"Wolf G, Chen S, Ziyadeh FN. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes. 2005;54(6):1626\u201334.","journal-title":"Diabetes"},{"issue":"18","key":"2173_CR5","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2169\/internalmedicine.48.2137","volume":"48","author":"M Miyauchi","year":"2009","unstructured":"Miyauchi M, Toyoda M, Kobayashi K, Abe M, Kobayashi T, Kato M, Yamamoto N, Kimura M, Umezono T, Suzuki D. Hypertrophy and loss of podocytes in diabetic nephropathy. Intern Med. 2009;48(18):1615\u201320.","journal-title":"Intern Med"},{"issue":"1","key":"2173_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrg.2015.10","volume":"17","author":"JJ Quinn","year":"2016","unstructured":"Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17(1):47\u201362.","journal-title":"Nat Rev Genet"},{"issue":"13","key":"2173_CR7","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.3390\/ijms20133276","volume":"20","author":"M Ignarski","year":"2019","unstructured":"Ignarski M, Islam R, M\u00fcller R-U. Long non-coding RNAs in kidney disease. Int J Mol Sci. 2019;20(13):3276.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2173_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41419-021-03466-5","volume":"12","author":"D Liu","year":"2021","unstructured":"Liu D, Liu Y, Zheng X, Liu N. c-MYC-induced long noncoding RNA MEG3 aggravates kidney ischemia-reperfusion injury through activating mitophagy by upregulation of RTKN to trigger the Wnt\/\u03b2-catenin pathway. Cell Death Dis. 2021;12(2):191.","journal-title":"Cell Death Dis"},{"issue":"2","key":"2173_CR9","volume":"53","author":"J Xu","year":"2020","unstructured":"Xu J, Deng Y, Wang Y, Sun X, Chen S, Fu G. SPAG5-AS1 inhibited autophagy and aggravated apoptosis of podocytes via SPAG5\/AKT\/mTOR pathway. Cell Prolif. 2020;53(2): e12738.","journal-title":"Cell Prolif"},{"key":"2173_CR10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2147\/DMSO.S225791","volume":"13","author":"B Zhu","year":"2020","unstructured":"Zhu B, Cheng X, Jiang Y, Cheng M, Chen L, Bao J, Tang X. Silencing of KCNQ1OT1 decreases oxidative stress and pyroptosis of renal tubular epithelial cells. Diabetes Metab Syndr Obes. 2020;13:365\u201375.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"2173_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s11010-020-03909-1","volume":"476","author":"J Li","year":"2021","unstructured":"Li J, Li M, Bai L. KCNQ1OT1\/miR-18b\/HMGA2 axis regulates high glucose-induced proliferation, oxidative stress, and extracellular matrix accumulation in mesangial cells. Mol Cell Biochem. 2021;476(1):321\u201331.","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"2173_CR12","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1177\/0300985813502820","volume":"51","author":"M Bhaskaran","year":"2014","unstructured":"Bhaskaran M, Mohan M. MicroRNAs: history, biogenesis, and their evolving role in animal development and disease. Vet Pathol. 2014;51(4):759\u201374.","journal-title":"Vet Pathol"},{"issue":"4","key":"2173_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.tibs.2007.02.006","volume":"32","author":"Y Zhao","year":"2007","unstructured":"Zhao Y, Srivastava D. A developmental view of microRNA function. Trends Biochem Sci. 2007;32(4):189\u201397.","journal-title":"Trends Biochem Sci"},{"issue":"6","key":"2173_CR14","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1681\/ASN.2016101117","volume":"28","author":"P Trionfini","year":"2017","unstructured":"Trionfini P, Benigni A. MicroRNAs as master regulators of glomerular function in health and disease. J Am Soc Nephrol. 2017;28(6):1686\u201396.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2173_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12943-017-0743-3","volume":"16","author":"H YiRen","year":"2017","unstructured":"YiRen H, Ying Cong Y, Sunwu Y, Keqin L, Xiaochun T, Senrui C, Ende C, XiZhou L, Yanfan C. Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric cancer. Mol Cancer. 2017;16(1):174.","journal-title":"Mol Cancer"},{"issue":"6","key":"2173_CR16","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1245\/s10434-020-09283-y","volume":"28","author":"M Hayashi","year":"2020","unstructured":"Hayashi M, Yamada S, Kurimoto K, Tanabe H, Hirabayashi S, Sonohara F, Inokawa Y, Takami H, Kanda M, Tanaka C, et al. miR-23b-3p plays an oncogenic role in hepatocellular carcinoma. Ann Surg Oncol. 2020;28(6):3416\u201326.","journal-title":"Ann Surg Oncol"},{"key":"2173_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13098-020-00539-x","volume":"12","author":"W Zhong","year":"2020","unstructured":"Zhong W, Zeng J, Xue J, Du A, Xu Y. Knockdown of lncRNA PVT1 alleviates high glucose-induced proliferation and fibrosis in human mesangial cells by miR-23b-3p\/WT1 axis. Diabetol Metab Syndr. 2020;12:33.","journal-title":"Diabetol Metab Syndr"},{"issue":"5","key":"2173_CR18","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1507\/endocrj.EJ20-0642","volume":"68","author":"D Yu","year":"2021","unstructured":"Yu D, Yang X, Zhu Y, Xu F, Zhang H, Qiu Z. Knockdown of plasmacytoma variant translocation 1 (PVT1) inhibits high glucose-induced proliferation and renal fibrosis in HRMCs by regulating miR-23b-3p\/early growth response factor 1 (EGR1). Endocr J. 2021;68(5):519\u201329.","journal-title":"Endocr J"},{"key":"2173_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.biocel.2015.11.016","volume":"70","author":"H Liu","year":"2016","unstructured":"Liu H, Wang X, Liu S, Li H, Yuan X, Feng B, Bai H, Zhao B, Chu Y, Li H. Effects and mechanism of miR-23b on glucose-mediated epithelial-to-mesenchymal transition in diabetic nephropathy. Int J Biochem Cell Biol. 2016;70:149\u201360.","journal-title":"Int J Biochem Cell Biol"},{"key":"2173_CR20","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3389\/fimmu.2020.00346","volume":"11","author":"V Iragavarapu-Charyulu","year":"2020","unstructured":"Iragavarapu-Charyulu V, Wojcikiewicz E, Urdaneta A. Semaphorins in angiogenesis and autoimmune diseases: therapeutic targets? Front Immunol. 2020;11:346.","journal-title":"Front Immunol"},{"issue":"16","key":"2173_CR21","doi-asserted-by":"publisher","first-page":"5641","DOI":"10.3390\/ijms21165641","volume":"21","author":"Q Lu","year":"2020","unstructured":"Lu Q, Zhu L. The role of semaphorins in metabolic disorders. Int J Mol Sci. 2020;21(16):5641.","journal-title":"Int J Mol Sci"},{"issue":"6600","key":"2173_CR22","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/383525a0","volume":"383","author":"O Behar","year":"1996","unstructured":"Behar O, Golden JA, Mashimo H, Schoen FJ, Fishman MC. Semaphorin III is needed for normal patterning and growth of nerves, bones and heart. Nature. 1996;383(6600):525\u20138.","journal-title":"Nature"},{"issue":"3","key":"2173_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058446","volume":"8","author":"C Jayakumar","year":"2013","unstructured":"Jayakumar C, Ranganathan P, Devarajan P, Krawczeski CD, Looney S, Ramesh G. Semaphorin 3A is a new early diagnostic biomarker of experimental and pediatric acute kidney injury. PLoS ONE. 2013;8(3): e58446.","journal-title":"PLoS ONE"},{"issue":"7","key":"2173_CR24","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1167\/iovs.16-19468","volume":"57","author":"SH Kwon","year":"2016","unstructured":"Kwon SH, Shin JP, Kim IT, Park DH. Association of plasma semaphorin 3A with phenotypes of diabetic retinopathy and nephropathy. Invest Ophthalmol Vis Sci. 2016;57(7):2983\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"2173_CR25","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.3390\/ijms21114099","volume":"21","author":"Y Sang","year":"2020","unstructured":"Sang Y, Tsuji K, Inoue-Torii A, Fukushima K, Kitamura S, Wada J. Semaphorin3A-inhibitor ameliorates doxorubicin-induced podocyte injury. Int J Mol Sci. 2020;21(11):4099.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2173_CR26","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.2337\/db14-0719","volume":"64","author":"PK Aggarwal","year":"2015","unstructured":"Aggarwal PK, Veron D, Thomas DB, Siegel D, Moeckel G, Kashgarian M, Tufro A. Semaphorin3a promotes advanced diabetic nephropathy. Diabetes. 2015;64(5):1743\u201359.","journal-title":"Diabetes"},{"key":"2173_CR27","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.3389\/fimmu.2019.01560","volume":"10","author":"K Gao","year":"2019","unstructured":"Gao K, Jin J, Huang C, Li J, Luo H, Li L, Huang Y, Jiang Y. Exosomes derived from septic mouse serum modulate immune responses via exosome-associated cytokines. Front Immunol. 2019;10:1560.","journal-title":"Front Immunol"},{"issue":"3","key":"2173_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010310","volume":"6","author":"M Lindhardt","year":"2016","unstructured":"Lindhardt M, Persson F, Currie G, Pontillo C, Beige J, Delles C, von der Leyen H, Mischak H, Navis G, Noutsou M. Proteomic prediction and renin angiotensin aldosterone system Inhibition prevention of early diabetic nephRopathy in type 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial. BMJ Open. 2016;6(3): e010310.","journal-title":"BMJ Open"},{"key":"2173_CR29","first-page":"5383010","volume":"2019","author":"Y Li","year":"2019","unstructured":"Li Y, Xu K, Xu K, Chen S, Cao Y, Zhan H. Roles of identified long noncoding RNA in diabetic nephropathy. J Diabetes Res. 2019;2019:5383010.","journal-title":"J Diabetes Res"},{"issue":"10","key":"2173_CR30","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/s41419-018-1029-4","volume":"9","author":"F Yang","year":"2018","unstructured":"Yang F, Qin Y, Lv J, Wang Y, Che H, Chen X, Jiang Y, Li A, Sun X, Yue E, et al. Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy. Cell Death Dis. 2018;9(10):1000.","journal-title":"Cell Death Dis"},{"issue":"3","key":"2173_CR31","doi-asserted-by":"publisher","first-page":"C355","DOI":"10.1152\/ajpcell.00403.2020","volume":"320","author":"C Zhang","year":"2021","unstructured":"Zhang C, Gong Y, Li N, Liu X, Zhang Y, Ye F, Guo Q, Zheng J. Long noncoding RNA Kcnq1ot1 promotes sC5b-9-induced podocyte pyroptosis by inhibiting miR-486a-3p and upregulating. Am J Physiol Cell Physiol. 2021;320(3):C355\u201364.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2173_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cca.2019.02.021","volume":"493","author":"BY Chen","year":"2019","unstructured":"Chen BY, Sung CW, Chen C, Cheng CM, Lin DP, Huang CT, Hsu MY. Advances in exosomes technology. Clin Chim Acta. 2019;493:14\u20139.","journal-title":"Clin Chim Acta"},{"issue":"6478","key":"2173_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478): eaau6977.","journal-title":"Science"},{"issue":"1","key":"2173_CR34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12943-018-0822-0","volume":"17","author":"SK Tan","year":"2018","unstructured":"Tan SK, Pastori C, Penas C, Komotar RJ, Ivan ME, Wahlestedt C, Ayad NG. Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme. Mol Cancer. 2018;17(1):74.","journal-title":"Mol Cancer"},{"issue":"3","key":"2173_CR35","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3233\/CBM-170727","volume":"21","author":"C Zhang","year":"2018","unstructured":"Zhang C, Yang X, Qi Q, Gao Y, Wei Q, Han S. lncRNA-HEIH in serum and exosomes as a potential biomarker in the HCV-related hepatocellular carcinoma. Cancer Biomark. 2018;21(3):651\u20139.","journal-title":"Cancer Biomark"},{"issue":"2","key":"2173_CR36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ncrna.2020.03.001","volume":"5","author":"VA Tello-Flores","year":"2020","unstructured":"Tello-Flores VA, Valladares-Salgado A, Ram\u00edrez-Vargas MA, Cruz M, Del-Moral-Hern\u00e1ndez O, Cahua-Pablo J, Ram\u00edrez M, Hern\u00e1ndez-Sotelo D, Armenta-Solis A, Flores-Alfaro E. Altered levels of MALAT1 and H19 derived from serum or serum exosomes associated with type-2 diabetes. Non-Coding RNA Res. 2020;5(2):71\u20136.","journal-title":"Non-Coding RNA Res"},{"key":"2173_CR37","doi-asserted-by":"crossref","unstructured":"Liu L, Duan A, Li H, Luo P: MiR-23b inhibits oxidative stress in mice with Diabetic Nephropathy targeting MAPK. Panminerva Med. 2020.","DOI":"10.23736\/S0031-0808.20.04179-8"},{"issue":"9","key":"2173_CR38","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1681\/ASN.2015030300","volume":"27","author":"B Zhao","year":"2016","unstructured":"Zhao B, Li H, Liu J, Han P, Zhang C, Bai H, Yuan X, Wang X, Li L, Ma H, et al. MicroRNA-23b targets Ras GTPase-activating protein SH3 domain-binding protein 2 to alleviate fibrosis and albuminuria in diabetic nephropathy. J Am Soc Nephrol. 2016;27(9):2597\u2013608.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"2173_CR39","doi-asserted-by":"publisher","first-page":"20869","DOI":"10.1002\/jcp.28691","volume":"234","author":"Y Fu","year":"2019","unstructured":"Fu Y, Wang C, Zhang D, Chu X, Zhang Y, Li J. miR-15b-5p ameliorated high glucose-induced podocyte injury through repressing apoptosis, oxidative stress, and inflammatory responses by targeting Sema3A. J Cell Physiol. 2019;234(11):20869\u201378.","journal-title":"J Cell Physiol"},{"issue":"23","key":"2173_CR40","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1242\/dev.037267","volume":"136","author":"KJ Reidy","year":"2009","unstructured":"Reidy KJ, Villegas G, Teichman J, Veron D, Shen W, Jimenez J, Thomas D, Tufro A. Semaphorin3a regulates endothelial cell number and podocyte differentiation during glomerular development. Development. 2009;136(23):3979\u201389.","journal-title":"Development"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-021-02173-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-021-02173-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-021-02173-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T05:21:29Z","timestamp":1650086489000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-021-02173-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,8]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["2173"],"URL":"https:\/\/doi.org\/10.1007\/s10157-021-02173-x","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,8]]},"assertion":[{"value":"20 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present study was approved by the ethical review committee of The Affiliated Huaian No.1 People\u2019s Hospital of Nanjing Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all enrolled patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Patients agree to participate in this work.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}